Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H17N3O |
| Molecular Weight | 339.3899 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(C=CC=C1)N2C(=O)C3=CC=CC=C3N=C2C=CC4=NC=CC=C4
InChI
InChIKey=MYGZNGAHFWOCLI-UHFFFAOYSA-N
InChI=1S/C22H17N3O/c1-16-8-2-5-12-20(16)25-21(14-13-17-9-6-7-15-23-17)24-19-11-4-3-10-18(19)22(25)26/h2-15H,1H3
| Molecular Formula | C22H17N3O |
| Molecular Weight | 339.3899 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Atropisomeric quinazolin-4-one derivatives are potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists. | 2001-01-22 |
|
| Effect of acute and chronic treatment of phenobarbital and chloroquin on the turnover of 2- [2-(3-pyridyl)vinyl] -3-o-tolyl-3,4-dihydro quinazoline-4-one (SRC-909). | 1979-07 |
|
| Neuromuscular blocking action of 2-(2-(3-pyridyl) vinyl)-3-0-tolyl-3, 4-dihydroquinazoline-4-one (SRC 909). | 1974-06 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:09:34 GMT 2025
by
admin
on
Mon Mar 31 18:09:34 GMT 2025
|
| Record UNII |
9O52U70AP4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C74139
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
PRIMARY | |||
|
DTXSID10862777
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
PRIMARY | |||
|
CHEMBL51620
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
PRIMARY | |||
|
100000081670
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
PRIMARY | |||
|
217-590-2
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
PRIMARY | |||
|
1897-89-8
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
PRIMARY | |||
|
96996
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
PRIMARY | |||
|
C005718
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
PRIMARY | |||
|
3165
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
PRIMARY | |||
|
9O52U70AP4
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
PRIMARY | |||
|
SUB09918MIG
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
PRIMARY | |||
|
63114
Created by
admin on Mon Mar 31 18:09:34 GMT 2025 , Edited by admin on Mon Mar 31 18:09:34 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|